The platform estimates one to two new GLP-1 drug launches per year beginning in 2026, with 39 GLP-1 medications currently in development
GLP-1 receptor agonists bind to GLP-1 receptors on pancreatic beta cells, stimulating glucose-dependent insulin secretion
60 In contrast, the long-acting enzyme resistant form of GLP-2, namely (Gly2)GLP-2, did not provide benefit on bone strength in a mouse model of bone fragility, 61 despite promoting the expression of bone matrix genes and reducing osteoclast number in the in vitro setting
Avoid supplements with non-halal gelatin capsules (opt for vegetarian capsules)
Diagnosis and Management of Treatment-Refractory Hypothyroidism: An expert consensus report
for instance, neither the mitochondria-targeting peptide Bendavia nor erythropoietin demonstrated significant benefits in clinical trials (Minamino et al., 2018